Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inhibrx Biosciences (INBX) Tax Provisions (2023 - 2025)

Historic Tax Provisions for Inhibrx Biosciences (INBX) over the last 3 years, with Q2 2025 value amounting to $2000.0.

  • Inhibrx Biosciences' Tax Provisions changed 0.0% to $2000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $2000.0, marking a year-over-year increase of 20000.0%. This contributed to the annual value of $2000.0 for FY2024, which is 3333.33% down from last year.
  • Inhibrx Biosciences' Tax Provisions amounted to $2000.0 in Q2 2025, which was down 0.0% from $2000.0 recorded in Q2 2024.
  • In the past 5 years, Inhibrx Biosciences' Tax Provisions registered a high of $5000.0 during Q2 2023, and its lowest value of -$4000.0 during Q4 2023.
  • Moreover, its 3-year median value for Tax Provisions was $2000.0 (2023), whereas its average is $1400.0.
  • As far as peak fluctuations go, Inhibrx Biosciences' Tax Provisions crashed by 6000.0% in 2024, and later changed by 0.0% in 2025.
  • Inhibrx Biosciences' Tax Provisions (Quarter) stood at -$4000.0 in 2023, then skyrocketed by 150.0% to $2000.0 in 2024, then changed by 0.0% to $2000.0 in 2025.
  • Its last three reported values are $2000.0 in Q2 2025, $2000.0 for Q2 2024, and -$4000.0 during Q4 2023.